text.skipToContent text.skipToNavigation
Need help? Please contact us

Human CD19+ B Cells (10 Million Cells, Negative Selection)

Catalog #: 2W-601

Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells

 1’740.00 CHF
Compare
AMP

Product Overview

CD19+ B cells are negatively selected from leukapheresed peripheral blood MNCs using an immunomagnetic labeling system to remove unwanted cell types.

Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols.

Applications

  • Generating antibody libraries
  • Co-culture with T helper cells or cytotoxic lymphocytes (CTL)
  • B cell activation, clonal expansion, Ig rearrangement, and Ig secretion
  • Antigen presenting cell (APC) signal transduction and antigen presentation

Content & Storage

Content

1 vial containing ≥ 10 million cryopreserved cells

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.